New biotech twist, Givaudan’s PrimalHyal 300 targets skin repair

With PrimalHyal 300, Givaudan is pushing into biotech-driven skincare actives that promise stronger skin repair and hydration. The hyaluronic acid ingredient is aimed at premium face care formulas as demand for science-backed cosmetic ingredients accelerates.

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 8:44 AM ET. Details in the imprint.

PrimalHyal 300 is Givaudan’s latest hyaluronic-acid-based active designed to support skin repair, signaling how far the Swiss fragrance and beauty-ingredients specialist has moved into high-value cosmetic actives. The biotech ingredient is positioned for use in serums, creams and other leave-on face care where brands want both hydration claims and a visible boost to barrier recovery, reflecting the shift toward science-led skincare ingredients.

What Givaudan’s PrimalHyal 300 is built to do

Givaudan describes PrimalHyal 300 as a specific grade of hyaluronic acid developed for topical applications that target skin repair and resilience, sitting alongside its broader PrimalHyal portfolio of low and high molecular weight fractions intended to improve hydration and suppleness in finished formulas. The company presents the ingredient for formulators who want measurable improvements in skin comfort and recovery after stress, rather than simply positioning it as another generic moisture booster, and highlights its compatibility with typical emulsion and gel textures used in modern face care. Givaudan’s own PrimalHyal range overview describes the line as a toolbox of hyaluronic solutions tailored to distinct skin needs.

At trade shows and industry events, the company has been showcasing PrimalHyal 300 as part of a broader toolbox of biotech-derived actives that address post-stress skin, a theme that aligns with rising consumer interest in skin-barrier support and recovery-focused routines in markets from North America to India. In coverage of the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day, where suppliers present their latest materials to chemists, PrimalHyal 300 has been highlighted as a key Givaudan exhibit aimed at skin repair concepts, underlining its relevance for brand owners looking to formulate recovery serums and barrier creams. Personal Care Insights notes Givaudan featuring PrimalHyal 300 around skin repair storylines at NYSCC Suppliers’ Day.

Functionally, PrimalHyal 300 fits into the broader market shift toward bio-based cosmetic ingredients, where suppliers aim to offer traceability, safety data and in-vitro or clinical support for performance claims rather than relying only on traditional emollients and humectants. Market analyses of bio-based cosmetics and personal-care ingredients point to Givaudan as one of the industry players expected to benefit from brands’ pivot to sustainable, science-backed actives, with demand rising for materials that can underpin claims such as improved barrier function, reduced discomfort and better hydration over time. A recent GlobeNewswire-backed market report summarized Givaudan among the key suppliers in the growing bio-based cosmetics ingredients segment.

PrimalHyal 300 is not a finished consumer cream but an intermediate ingredient sold business-to-business, meaning its commercial success depends on how many skincare brands incorporate it into their own formulations for global retail. For formulators, the practical questions are therefore less about the product name on the shelf and more about performance in stability testing, compatibility with common preservatives and surfactant systems, and whether the ingredient can support clear front-of-pack claims on hydration or repair without regulatory issues across key markets.

Within Givaudan’s portfolio, PrimalHyal 300 strengthens the company’s Active Beauty unit, which has become an important vector for diversification beyond traditional fragrance and flavor activities as beauty brands search for distinctive ingredients. The move reflects a broader strategic push to capture value higher up the skincare supply chain and support customers that are repositioning their ranges around repair, resilience and barrier health, especially in fast-growing beauty markets in Asia and India where demand for advanced actives is accelerating. Shares of Givaudan (CH0010645932) traded on SIX Swiss Exchange at CHF 4,280.00 on 06/13/2026.

PrimalHyal 300 by Givaudan in brief

• Product: PrimalHyal 300
• Manufacturer: Givaudan SA
• Category: New Release/Launch - cosmetic active ingredient
• Launch date: Highlighted in recent trade-show coverage around NYSCC Suppliers’ Day 2026
• MSRP / Price: Not disclosed (sold B2B to cosmetic manufacturers)
• Availability: Distributed to skincare and cosmetics formulators via Givaudan’s Active Beauty business worldwide
• Target audience: Cosmetic chemists and skincare brands developing repair-focused, hydrating face care products
• Key differentiator / USP: Hyaluronic-acid-based active positioned specifically for skin repair and barrier-support concepts, as part of Givaudan’s biotech-derived PrimalHyal portfolio

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.